# The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy

> **NCT04672252** · PHASE2,PHASE3 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 100 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** CBD Oral Disintegrating Tablet (ODT)
- **OTHER:** Placebo ODT

## Key facts

- **NCT ID:** NCT04672252
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-12-16
- **Final completion:** 2022-12-16
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04672252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04672252, "The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04672252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*